Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_assertion type Assertion NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_head.
- NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_assertion description "[Epidermal growth factor receptor (EGFR) transmembrane glycoprotein has been demonstrated to be overexpressed in pancreatic cancer, and it correlates with more advanced disease, poor survival, and the presence of metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_provenance.
- NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_assertion evidence source_evidence_literature NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_provenance.
- NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_assertion SIO_000772 23560505 NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_provenance.
- NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_assertion wasDerivedFrom befree-20140225 NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_provenance.
- NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_assertion wasGeneratedBy ECO_0000203 NP609614.RAXUw-VdzdOqLS9Wm7vURdTM-YLIPIM7wCG523LO_Y3SY130_provenance.